Summary
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Melanotan I is more often discussed in the realm of Dermatology and aesthetics, whereas Sermorelin is more often associated with the realm of Metabolic and endocrine and Aging and longevity. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Melanotan I leaning toward Melanogenesis modulation and Sermorelin leaning toward Anabolic growth and Lipolysis and fat loss. Both are synthetic in origin and their development context also differs, with Melanotan I approved for Research use only while Sermorelin is approved. Melanotan I carries d-amino acid substitution features, while Sermorelin instead reflects amidation changes, while their sequence patterns also diverge, with Melanotan I showing protein-mimetic sequence features and Sermorelin showing alpha-helical domain features.